RECURRENT ACHALASIA IN A GERIATRIC PATIENT - A THERAPEUTIC CHALLENGE

  • Andreea Ștefania Bușagă ”Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
  • Petre Hoară General Surgery Department, “Sf. Maria” Clinical Hospital, Bucharest, Romania & ”Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
  • Rodica Bârlă General Surgery Department, “Sf. Maria” Clinical Hospital, Bucharest, Romania & ”Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
  • Silviu Constantinoiu General Surgery Department, “Sf. Maria” Clinical Hospital, Bucharest, Romania & ”Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
  • Octavian Andronic General Surgery Department, University Emergency Hospital of Bucharest, Romania & “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
  • Alexandru Constantinescu Gastroenterology Department, University Emergency Hospital of Bucharest, Romania & Carol Davila University of Medicine and Pharmacy, Bucharest Romania
  • Alkadour Abdullah General Surgery Department, “Sf. Maria” Clinical Hospital, Bucharest, Romania & ”Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
Keywords: achalasia, geriatric patient, elderly, treatment, motility dysfunction

Abstract

Achalasia is an esophageal motility dysfunction characterized by the lack of peristalsis and insufficient relaxation of the lower esophageal sphincter on swallowing. This study aims to analyze the therapeutic options currently used in the treatment of recurrent achalasia and to compare their effectiveness in the geriatric patient. Extreme age poses problems with therapy, so the present paper seeks to demonstrate that the surgical approach, although usually avoided or delayed in this age group, due to the additional risks involved, may be the elective therapy for the treatment of recurrent achalasia in the elderly. Following a rigorous search, 47 studies were selected regarding the methods of treatment and the evolution over time of the symptoms of achalasia, excluding case presentations related to the subject. The treatment of geriatric patients should be based only on the physiological status not age, and laparoscopic Heller myotomy can be the first treatment option, noting that it is very important to consider the manometric subtype, which provides information about the prognosis and the most appropriate form of treatment.

References

[1] “Ursut 2014”.
[2] X. J. Liu et al., “The outcomes and quality of life of patients with achalasia after peroral endoscopic myotomy in the short-term,” Annals of Thoracic and Cardiovascular Surgery, vol. 21, no. 6, pp. 507–512, Dec. 2015, doi: 10.5761/atcs.oa.15-00066.
[3] M. F. Vaezi, J. E. Pandolfino, R. H. Yadlapati, K. B. Greer, and R. T. Kavitt, “ACG Clinical Guidelines: Diagnosis and Management of Achalasia,” Am J Gastroenterol, vol. 115, no. 9, pp. 1393–1411, Sep. 2020, doi: 10.14309/ajg.0000000000000731.
[4] H. Rashid, K. Bakht, A. Arslan, and A. Ahmad, “Endoscopic Findings and Their Association With Gender, Age and Duration of Symptoms in Patients With Dysphagia,” Cureus, Oct. 2020, doi: 10.7759/cureus.11264.
[5] N. Ujiie et al., “Characteristics of esophageal achalasia in geriatric patients over 75 years of age and outcomes after peroral endoscopic myotomy,” Geriatrics and Gerontology International, vol. 21, no. 9, pp. 788–793, Sep. 2021, doi: 10.1111/ggi.14235.
[6] C. Zhong et al., “Role of Peroral Endoscopic Myotomy in Geriatric Patients with Achalasia: A Systematic Review and Meta-Analysis,” Digestive Diseases, vol. 40, no. 1. S. Karger AG, pp. 106–114, Jan. 01, 2022. doi: 10.1159/000516024.
[7] G. H. Kim et al., “Superior clinical outcomes of peroral endoscopic myotomy compared with balloon dilation in all achalasia subtypes,” Journal of Gastroenterology and Hepatology (Australia), vol. 34, no. 4, pp. 659–665, Apr. 2019, doi: 10.1111/jgh.14616.
[8] E. D. Kane, D. J. Desilets, D. Wilson, M. Leduc, V. Budhraja, and J. R. Romanelli, “Treatment of Achalasia with Per-Oral Endoscopic Myotomy: Analysis of 50 Consecutive Patients,” Journal of Laparoendoscopic and Advanced Surgical Techniques, vol. 28, no. 5, pp. 514–525, May 2018, doi: 10.1089/lap.2017.0588.
[9] F. Borhan-Manesh, M. J. Kaviani, and A. R. Taghavi, “The efficacy of balloon dilation in achalasia is the result of stretching of the lower esophageal sphincter, not muscular disruption,” Diseases of the Esophagus, vol. 29, no. 3, pp. 262–266, Apr. 2016, doi: 10.1111/dote.12314.
[10] F. Schlottmann, C. Andolfi, R. T. Kavitt, V. J. A. Konda, and M. G. Patti, “Multidisciplinary Approach to Esophageal Achalasia: A Single Center Experience,” Journal of Laparoendoscopic and Advanced Surgical Techniques, vol. 27, no. 4, pp. 358–362, Apr. 2017, doi: 10.1089/lap.2016.0594.
[11] M. G. Patti et al., “Minimally Invasive Surgery for Achalasia An 8-Year Experience With 168 Patients,” 1999.
[12] O. R. Zotti et al., “Achalasia Treatment in Patients over 80 Years of Age: A Multicenter Survey,” Journal of Laparoendoscopic and Advanced Surgical Techniques, vol. 30, no. 4. Mary Ann Liebert Inc., pp. 358–362, Apr. 01, 2020. doi: 10.1089/lap.2019.0749.
[13] Y. Vigneswaran, A. K. Yetasook, J. C. Zhao, W. Denham, J. G. Linn, and M. B. Ujiki, “Peroral Endoscopic Myotomy (POEM): Feasible as Reoperation Following Heller Myotomy,” Journal of Gastrointestinal Surgery, vol. 18, no. 6, pp. 1071–1076, 2014, doi: 10.1007/s11605-014-2496-2.
[14] H. Yamashita et al., “Predictive factors associated with the success of pneumatic dilatation in japanese patients with primary achalasia: A study using high-resolution manometry,” in Digestion, Jan. 2013, vol. 87, no. 1, pp. 23–28. doi: 10.1159/000343902.
[15] V. F. Eckardt, I. Gockel, and G. Bernhard, “Pneumatic dilation for achalasia: Late results of a prospective follow up investigation,” Gut, vol. 53, no. 5, pp. 629–633, May 2004, doi: 10.1136/gut.2003.029298.
[16] L. Qian et al., “Long-term efficacy of pneumatic dilation and esophageal stenting for the treatment of achalasia,” Digestion, vol. 88, no. 4, pp. 209–216, 2013, doi: 10.1159/000355207.
[17] S. Spiliopoulos et al., “Fluoroscopically guided balloon dilatation for the treatment of achalasia: Long-term outcomes,” Diseases of the Esophagus, vol. 26, no. 3, pp. 213–218, Apr. 2013, doi: 10.1111/j.1442-2050.2012.01360.x.
[18] A. Agrusa, G. Romano, S. Bonventre, G. Salamone, G. Cocorullo, and G. Gulotta, “Laparoscopic treatment for esophageal achalasia: Experience at a single center,” Giornale di Chirurgia, vol. 34, no. 7–8, pp. 220–223, Jul. 2013, doi: 10.11138/gchir/2013.34.7.220.
[19] T. R. Elliott, P. I. Wu, S. Fuentealba, M. Szczesniak, D. J. de Carle, and I. J. Cook, “Long-term outcome following pneumatic dilatation as initial therapy for idiopathic achalasia: An 18-year single-centre experience,” Alimentary Pharmacology and Therapeutics, vol. 37, no. 12, pp. 1210–1219, Jun. 2013, doi: 10.1111/apt.12331.
[20] A. M. Aljebreen, S. Samarkandi, T. Al-Harbi, H. Al-Radhi, and M. A. Almadi, “Efficacy of pneumatic dilatation in Saudi achalasia patients,” Saudi Journal of Gastroenterology, vol. 20, no. 1, pp. 43–47, Jan. 2014, doi: 10.4103/1319-3767.126317.
[21] A. T. Javed, K. Batte, M. Khalaf, M. Abdul-Hussein, P. S. Elias, and D. O. Castell, “Durability of pneumatic dilation monotherapy in treatment-naive Achalasia patients,” BMC Gastroenterology, vol. 19, no. 1, Nov. 2019, doi: 10.1186/s12876-019-1104-z.
[22] S. M. Chan et al., “Laparoscopic Heller’s cardiomyotomy achieved lesser recurrent dysphagia with better quality of life when compared with endoscopic balloon dilatation for treatment of achalasia,” Diseases of the Esophagus, vol. 26, no. 3, pp. 231–236, Apr. 2013, doi: 10.1111/j.1442-2050.2012.01357.x.
[23] F. Zerbib, V. Thétiot, F. Richy, D. A. Benajah, L. Message, and H. Lamouliatte, “Repeated pneumatic dilations as long-term maintenance therapy for esophageal achalasia,” American Journal of Gastroenterology, vol. 101, no. 4, pp. 692–697, Apr. 2006, doi: 10.1111/j.1572-0241.2006.00385.x.
[24] P. Cheng et al., “Clinical effect of endoscopic pneumatic dilation for Achalasia,” Medicine (United States), vol. 94, no. 28, Jul. 2015, doi: 10.1097/MD.0000000000001193.
[25] T. Sawas et al., “The course of achalasia one to four decades after initial treatment,” Alimentary Pharmacology and Therapeutics, vol. 45, no. 4, pp. 553–560, Feb. 2017, doi: 10.1111/apt.13888.
[26] B. R. Veenstra, R. F. Goldberg, S. P. Bowers, M. Thomas, R. A. Hinder, and C. D. Smith, “Revisional surgery after failed esophagogastric myotomy for achalasia: successful esophageal preservation,” Surgical Endoscopy, vol. 30, no. 5, pp. 1754–1761, May 2016, doi: 10.1007/s00464-015-4423-3.
[27] V. Kumbhari, J. Behary, M. Szczesniak, T. Zhang, and I. J. Cook, “Efficacy and safety of pneumatic dilatation for achalasia i. The treatment of post-myotomy symptom relapse,” American Journal of Gastroenterology, vol. 108, no. 7, pp. 1076–1081, Jul. 2013, doi: 10.1038/ajg.2013.32.
[28] D. R. C. James et al., “The feasibility, safety and outcomes of laparoscopic re-operation for achalasia,” Minimally Invasive Therapy and Allied Technologies, vol. 21, no. 3. pp. 161–167, May 2012. doi: 10.3109/13645706.2011.588798.
[29] S. Ngamruengphong et al., “Efficacy and Safety of Peroral Endoscopic Myotomy for Treatment of Achalasia After Failed Heller Myotomy,” Clinical Gastroenterology and Hepatology, vol. 15, no. 10, pp. 1531-1537.e3, Oct. 2017, doi: 10.1016/j.cgh.2017.01.031.
[30] S. R. Markar, T. Wiggins, H. MacKenzie, O. Faiz, G. Zaninotto, and G. B. Hanna, “Incidence and risk factors for esophageal cancer following achalasia treatment: National population-based case-control study,” Diseases of the Esophagus, vol. 32, no. 5, May 2019, doi: 10.1093/dote/doy106.
[31] U. Fumagalli et al., “Repeated Surgical or Endoscopic Myotomy for Recurrent Dysphagia in Patients After Previous Myotomy for Achalasia,” Journal of Gastrointestinal Surgery, vol. 20, no. 3, pp. 494–499, Mar. 2016, doi: 10.1007/s11605-015-3031-9.
[32] R. D. Stewart, J. Hawel, D. French, D. Bethune, and J. Ellsmere, “S093: pneumatic balloon dilation for palliation of recurrent symptoms of achalasia after esophagomyotomy,” Surgical Endoscopy, vol. 32, no. 9, pp. 4017–4021, Sep. 2018, doi: 10.1007/s00464-018-6271-4.
[33] G. Zaninotto et al., “Four hundred laparoscopic myotomies for esophageal achalasia a single centre experience,” Annals of Surgery, vol. 248, no. 6, pp. 986–993, Dec. 2008, doi: 10.1097/SLA.0b013e3181907bdd.
[34] L. Legros et al., “Long-term results of pneumatic dilatation for relapsing symptoms of achalasia after Heller myotomy,” Neurogastroenterol Motil, vol. 26, no. 9, pp. 1248–1255, Sep. 2014, doi: 10.1111/nmo.12380.
[35] C. M. G. Saleh, F. A. M. Ponds, M. P. Schijven, A. J. P. M. Smout, and A. J. Bredenoord, “Efficacy of pneumodilation in achalasia after failed Heller myotomy,” Neurogastroenterology and Motility, vol. 28, no. 11, pp. 1741–1746, Nov. 2016, doi: 10.1111/nmo.12875.
[36] L. Andrási et al., “Surgical treatment of esophageal achalasia in the era of minimally invasive surgery,” Journal of the Society of Laparoendoscopic Surgeons, vol. 25, no. 1. Society of Laparoendoscopic Surgeons, 2021. doi: 10.4293/JSLS.2020.00099.
[37] P. H. Zhou et al., “Peroral endoscopic remyotomy for failed Heller myotomy: A prospective single-center study,” Endoscopy, vol. 45, no. 3, pp. 161–166, 2013, doi: 10.1055/s-0032-1326203.
[38] A. Tyberg et al., “Peroral endoscopic myotomy as salvation technique post-Heller: International experience,” Digestive Endoscopy, vol. 30, no. 1, pp. 52–56, Jan. 2018, doi: 10.1111/den.12918.
[39] T. C. B. Dehn, M. Slater, N. J. Trudgill, P. M. Safranek, and M. I. Booth, “Laparoscopic stapled cardioplasty for failed treatment of achalasia,” British Journal of Surgery, vol. 99, no. 9, pp. 1242–1245, Sep. 2012, doi: 10.1002/bjs.8816.
[40] M. F. Loviscek et al., “Recurrent dysphagia after Heller myotomy: Is esophagectomy always the answer?,” J Am Coll Surg, vol. 216, no. 4, pp. 736–743, 2013, doi: 10.1016/j.jamcollsurg.2012.12.008.
[41] M. Onimaru et al., “Peroral endoscopic myotomy is a viable option for failed surgical esophagocardiomyotomy instead of redo surgical Heller myotomy: A single center prospective study,” J Am Coll Surg, vol. 217, no. 4, pp. 598–605, 2013, doi: 10.1016/j.jamcollsurg.2013.05.025.
[42] J. Martinek et al., “Per-oral endoscopic myotomy (POEM): mid-term efficacy and safety,” Surgical Endoscopy, vol. 32, no. 3, pp. 1293–1302, Mar. 2018, doi: 10.1007/s00464-017-5807-3.
[43] F. Aslan et al., “The last innovation in achalasia treatment; per-oral endoscopic myotomy,” Turkish Journal of Gastroenterology, vol. 26, no. 3, pp. 218–223, May 2015, doi: 10.5152/tjg.2015.0150.
[44] F. B. van Hoeij et al., “Management of recurrent symptoms after per-oral endoscopic myotomy in achalasia,” Gastrointestinal Endoscopy, vol. 87, no. 1, pp. 95–101, Jan. 2018, doi: 10.1016/j.gie.2017.04.036.
[45] Y. Liao et al., “Endoscopic ultrasound-measured muscular thickness of the lower esophageal sphincter and long-term prognosis after peroral endoscopic myotomy for achalasia,” World Journal of Gastroenterology, vol. 26, no. 38, pp. 5863–5873, Oct. 2020, doi: 10.3748/wjg.v26.i38.5863.
[46] Q. L. Li et al., “Repeat peroral endoscopic myotomy: A salvage option for persistent/recurrent symptoms,” Endoscopy, vol. 48, no. 2, pp. 134–140, Feb. 2016, doi: 10.1055/s-0034-1393095.
[47] A. Tyberg et al., “A multicenter international registry of redo per-oral endoscopic myotomy (POEM) after failed POEM,” Gastrointestinal Endoscopy, vol. 85, no. 6, pp. 1208–1211, Jun. 2017, doi: 10.1016/j.gie.2016.10.015.
Published
2022-12-27
How to Cite
[1]
A. Bușagă, “RECURRENT ACHALASIA IN A GERIATRIC PATIENT - A THERAPEUTIC CHALLENGE”, JSS, vol. 9, no. 4, Dec. 2022.